Join

Compare · MOVE vs TMDX

MOVE vs TMDX

Side-by-side comparison of Corvex Inc. (MOVE) and TransMedics Group Inc. (TMDX): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both MOVE and TMDX operate in Biotechnology: Electromedical & Electrotherapeutic Apparatus (Health Care), so they compete in similar markets.
  • TMDX is the larger of the two at $2.57B, about 77.6x MOVE ($33.1M).
  • Over the past year, MOVE is up 209.5% and TMDX is down 47.2% - MOVE leads by 256.7 points.
  • TMDX has been more active in the news (12 items in the past 4 weeks vs 8 for MOVE).
  • TMDX has more recent analyst coverage (18 ratings vs 0 for MOVE).
PerformanceMOVE+209.49%TMDX-47.21%
2025-06-10+0.00%2026-06-09
MetricMOVETMDX
Company
Corvex Inc.
TransMedics Group Inc.
Price
$17.11-3.11%
$74.36+4.47%
Market cap
$33.1M
$2.57B
1M return
+21.73%
+9.69%
1Y return
+209.49%
-47.21%
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Exchange
NASDAQ
NASDAQ
IPO
2021
2019
News (4w)
8
12
Recent ratings
0
18
MOVE

Corvex Inc.

Movano Inc., a technology company, develops a smart wearable and continuous glucose monitoring device. Its device enables individuals and their healthcare partners to measure and manage their health conditions. Movano Inc. was formerly known as Maestro Sensors Inc. and changed its name to Movano Inc. in August 2018. The company was incorporated in 2018 and is based in Pleasanton, California.

TMDX

TransMedics Group Inc.

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG, a portable perfusion, ventilation, and monitoring system that maintains the organ at a near-physiologic state allowing physicians to assess and improve the condition of lungs between the donor and recipient sites; OCS Heart, a portable, warm perfusion, and monitoring system designed to keep a donor heart at a human-like, metabolically active state; and OCS Liver, a system that is evaluated in clinical trials for utilized and unutilized donor livers. TransMedics Group, Inc. was founded in 1998 and is headquartered in Andover, Massachusetts.

Latest MOVE

Latest TMDX